Autoimmune destruction of b cells in the pancreas leads to type I, or insulin dependent diabetes mellitus (IDDM), through the loss of endogenous insulin production capacity. This paper describes an attempt to generate 'artificial' b cells using the fibroblast cell line BHK21. Stable transfectants expressing the human preproinsulin (PPI) gene were isolated and characterised. The resulting clone selected for further analysis (BHK-PPI-C16) was capable of 5 secreting 0.12 pmol proinsulin / hr / 10 cells and maintained a steady cellular proinsulin content of 0.36 6 0.04 21 pmol l . There was no processing of the proinsulin to mature insulin. The cells were unresponsive to glucose but there was increased proinsulin secretion in the presence of agents that stimulated formation of intracellular cAMP. Transfection of cDNAs for the key elements of the glucose sensing apparatus (GLUT2 and glucokinase) led to a subphysiological stimulation of secretion when glucokinase was transfected alone while there was a complete loss of insulin secretion when both components were overexpressed. The deleterious effect on proinsulin secretion observed upon co-expression of the glucose sensing genes may have implications for applications requiring multigene expression in BHK21 cells.
Introduction
markers / antigens that led to the autoimmune destruction of the host b cells. Diabetes Mellitus (Type I diabetes) is the direct result Previous studies have used hepatocytes, neuroenof the autoimmune destruction of insulin producing b docrine cells, CHO cells, and fibroblasts (Simpson et Taniguchi et al. 1997) . These have exhibited continuous regulation of insulin levels that is normalvarying levels of success, however none have as yet ly effected by b cells in response to fluctuations in been considered as suitable material for human blood glucose levels. An ideal therapy for the disorder therapy. would involve the implantation of cells which secrete Secretion of processed insulin was achieved in the insulin in response to physiologically relevant elevaneuroendocrine cell line AtT-20 (Hughes et al. 1991) . tions in blood glucose levels in order to maintain
The prohormone convertase enzymes PC2 and PC3 normoglycemia.
facilitated processing of the proinsulin. These cells Non-b, immortalised cell lines have been utilised in demonstrated regulatable secretion when stimulated experiments to generate replacement or artificial b by dibutyryl cyclic adenosine monophosphate (db cells. These cells are available in large numbers and cAMP) but did not exhibit glucose stimulated insulin represent a self-replicating source of transplant masecretion (GSIS), thus the cells were seen to exhibit a terial. The fact that the cells are not b cells is also regulatable insulin secretion pathway similar, in part, advantageous, as they might not express all of the cell to that of b cells. It was found that the cells naturally expressed glucokinase but lacked glucose transporter In this study BHK-21 cells were chosen as a type 2 (GLUT2) expression (the other main comrecipient cell line for the human insulin gene. These ponent of the glucose sensing system in b cells).
cells have already been employed in a trial for amyotStable expression of GLUT2 cDNA in the AtT20-Ins rophic lateral sclerosis (ALS) where they were modicells led to GSIS although it was at subphysiological fied to secrete ciliary neurotrophic factor (CNTF) levels (Hughes et al. 1992) . Motoyoshi et al. (1998 ) (Aebischer et al. 1996 . Thus these cells are already demonstrated GSIS over the whole physiological characterised as being safe to implant into humans. In range with AtT20 cells by the co-transfection of addition to the human insulin gene, the glucose sens-GLUT2 and glucokinase. While these cells are aping genes, GLUT2 and glucokinase, were transfected proaching the ideal for an artificial b cell, the inherent in an attempt to confer regulated secretion on the secretion of adrenocorticotropic hormone (ACTH), cells. from these cells is undesirable. ACTH can increase glucocortocoid levels in the body, which has been associated with insulin resistance (Stewart et al.
Materials and methods 1994).
One of the first somatic therapy approaches to be Cell line culture taken involved the implantation of proinsulin secreting fibroblasts into diabetic mice (Selden et al. 1987) .
BHK-21 cells (ATCC CCL 10) were grown in modi-
These engineered Ltk cells constitutively released fied Eagle's medium (MEM) with 5.6 mmol l proinsulin. Implantation of the cells reduced the blood glucose, 1% L-glutamine, 1% non-essential amino glucose levels of the test animals to normoglycemic acids and 5% FCS. DLKP (a cell line established in levels within two weeks. The test animals subsequentour laboratory from a poorly differentiated lung ly died as a result of implant overgrowth leading to squamous cell carcinoma) was routinely cultured in severe hypoglycemia. This effect was also observed DMEM: Hams F12 5 1:1 supplemented with 5% by Kawakami et al. (1992) . To control the overgrowth FCS, 1% sodium pyruvate and 2 mM L-glutamine of implanted fibroblasts, they were entrapped in 5% (Law et al. 1992) . The murine b cell line, Min6, was agarose which prevented the overgrowth of the cells cultured in DMEM supplemented with 20% serum for up to 80 days (Taniguchi et al. 1997) . These (heat inactivated at 56 8C for 35 min). DLKP were entrapped fibroblasts were found to maintain norcultured at 37 8C. BHK-21 and Min6 cells were moglycemia in diabetic mice for an average of 30 cultured at 37 8C in an atmosphere of 95% air, 5% days (the range was from 7 to 50 days). Initial studies CO . Routine sterility checks, including screening for 2 with fibroblasts have all involved unprocessed proinMycoplasma, indicated that the cells were clear of sulin and in each normoglycemia was achieved via contamination. constitutive secretion. Proinsulin is bioactive, however its activity is 8% (Taniguchi et al. 1997) 
to 20%
Plasmid constructs (Falqui et al. 1999 ) of mature insulin. While steady release of insulin has been shown to aid in controlling Human preproinsulin (PPI) coding region (333 bp) normoglycemia in diabetes mellitus (Falqui et al. was cloned from a pancreatic cDNA library and 1999), regulatable secretion would be far more desirinserted into pTarget mammalian expression vector able. Previous studies indicate that fibroblasts lack the (Promega; Southampton, England), conferring genetcellular machinery for regulatable protein processing, icin resistance, resulting in the PPI construct (pT-PPI storage and secretion (Kelly 1985; Halban and Irmplasmid) . Sequencing was carried out to ensure no inger 1994). Processing of proinsulin in fibroblasts mismatches were included. Human GLUT2 cDNA has been overcome by mutating the proinsulin cDNA (P-7-GLUT2), a gift from Prof MA Permutt, so that it would be cleavable by the ubiquitous endoWashington University School of Medicine, St. Louis, protease furin (Falqui et al. 1999) . Regulation of as full length coding sequence of human islet glucose proinsulin secretion from fibroblasts has also been transporter in puC19 vector, was subcloned from the achieved, although at the transcriptional level by the KnpI-XbnI site and inserted into pcDNA3.1 / Zeocin use of a mMT1 promoter (Kawakami et al. 1992) .
(Invitrogen; Groningen, The Netherlands), resulting This promoter was positively regulated in the presin ZeoGLUT2 plasmid; human glucokinase (GCK) ence of divalent cations such as cadmium.
cDNA (phIGLK-2), a gift from Prof MA Permutt as full length coding sequence of human islet GCK GAGGAGCAATGATCTTGA 39 primers were in-1 cDNA in pBluescript SK vector, was subcloned into cluded with PPI primers, resulting in amplification of pcDNA3.1 / Hygromycin (Invitrogen), resulting in a 383 bp b-actin product. HygGCK plasmid.
Immunocytochemical analysis Stable transfection of cell lines
For immunocytochemical analysis, cells were grown 5 2
BHK-21 cells were seeded at 2 3 10 cells per 25 cm in 6 well plates, rinsed three times with PBS and fixed flask 24 hours prior to transfection. LipofectAMINE at 220 8C for 5 min in methanol, which had been TM PLUS reagent (GibcoBRL, Life Technologies; pre-chilled to 220 8C. Primary antibodies used were Paisley, Scotland) was used for all transfections.
as follows: insulin (Clone 5B6 / 6; monoclonal inHuman PPI (pT-PPI plasmid) was transfected alone sulin / proinsulin rat antibody raised in mouse (Biointo BHK-21 cells. Clonal populations (resistant to 1 genesis; Poole, England); 1 / 300 dilution in Tris-buf- transfections were further co-transfected with GLUT2 l NaCl, pH 7.4)). GLUT2 (AB1342: raised in and GCK which were selected with zeocin (100 rabbit; 1 / 300 dilution in TBS) (Chemicon, Harrow, cells by extracting with TriReagent (Sigma; Poole, dilute (1:5 in TBS) rabbit (for insulin and GCK England) according to the manufacturer's instrucanalyses) or swine serum (for GLUT2 analysis), as tions. First-strand cDNA was synthesised from 1 mg appropriate. Primary antibodies were added and incu-RNA using oligo dT primers (Oswel; Southampton, bated for 2 h at 37 8C or over-night at 4 8C. Secondary England). 5 ml cDNA was then amplified in a 50 ml antibodies were added for 30 min at room tempera-
21
PCR reaction solution containing 1.5 mmol l ture. This was followed by a further 30 min of GATCTTGA 39 primers were used, together with ml leupeptin (Sigma), 116 mg ml aprotinin GLUT2 and GCK primers, to amplify a 142 bp b-(Sigma) for 40 min on ice, sonicated and protein was actin product. Forward: 59 GAAATCGTGCGTGACquantified by Bradford assay. 50 mg aliquots of sam-ATTAAGGAGAAGCT 39 and (reverse): 59 TCAGples were separated by running at 250 V and 45 mA on a 10% polyacrylamide gel, proteins were transResults ferred onto nitrocellulose membranes (using a semidry transfer cell (Biorad)), and, in the case of GLUT2, Cell lines were blocked for 2 hours at room temperature with 5% semi-skimmed dried milk in TBS. For GCK Transfection of BHK21 cells with the pT-PPI plasmid 21 analysis, membranes were blocked for 2 hours at resulted in 20 clones resistant to 1 mg ml geneticin. room temperature with 2.5% semi-skimmed dried Analysis of the clones resulted in the selection of milk in TBS. Membranes were then probed overClone 16 (BHK-PPI-C16) for further analysis. Subnight, at 4 8C, with primary antibodies detailed in sequent cell populations were generated by transfect-''Immunocytochemical Analysis'', using appropriate ing BHK-PPI-C16 with the pcDNA3.1-GLUT2 plasdilutions (GLUT2, 1 / 5000; GCK, 1 / 100). Following mid (including the zeocin resistance gene) and the a series of washes, the membranes were probed with pcDNA3.1-GCK plasmid (including the hygromycin an appropriate peroxidase-labelled secondary antiresistance gene). Those cells successfully transfected body for 1 hour and visualised by chemiluminescence (either with glucokinase alone or both plasmids) were using ECL reagents (Amersham Pharmacia Biotech.; selected in increasing levels of antibiotics (in combiBuckinghamshire, England).
nation where appropriate) to final selection concen-
trations of 150 mg ml hygromycin, 100 mg ml 21 zeocin and 1 mg ml geneticin. This led to two Proinsulin and insulin content and secretion additional cell populations for analysis BHK-PPI-C16-GCK and BHK-PPI-C16-GCK-GLUT. Prior to insulin content and secretion analyses, 2 3 5 10 cells were seeded per well of 6-well plates and RNA analysis allowed to attach over-night. Following this, the cells were rinsed 3 times with PBS (pre-heated to 37 8C), to Expression of insulin, glucokinase, and GLUT2 remove proinsulin and insulin secreted over-night, mRNAs were confirmed by reverse transcriptase PCR and were subsequently incubated in glucose-free (RT-PCR). Proinsulin transcripts were found to be medium for 2 3 15 min. To assess proinsulin and present in the cell line BHK-PPI-C16 and were cominsulin cellular content and constitutive secretion, pletely absent in the untransfected BHK21 cells. cells were then exposed to serum-free medium conSimilarly the newly constructed cell populations taining 0.1% BSA for 0, 1, 2, 4, 8 and 24 h of (BHK-PPI-C16-GCK and BHK-PPI-C16-GCKincubation. Glucose-stimulated proinsulin and insulin GLUT) were found to contain PPI transcripts ( Figure  secretion were assessed following exposure to 0, 0.5,
1A). Human glucokinase mRNA and GLUT2 mRNA 1, 2, 5, 10, 15 and 20 mmol l glucose in serum-free were transcribed in the cell populations resulting from medium for 2 h. Following all incubations, medium the transfection of BHK-PPI-C16 with these cDNAs was collected for analysis. For measurements of in-( Figures 1B and 1C , respectively). There were low tracellular proinsulin and insulin content, cells were 21 levels of these mRNAs already in the cells not translysed in lysis buffer (20 mmol l Tris pH 8.0, 2 21 fected with the GLUT2 and glucokinase cDNAs, i.e., mmol l EGTA, 1% Triton X-100, 10% glycerol, 1.5
BHK21 and BHK-PPI-C16. b-actin (383 bp or 142 bp mmol l MgCl , 137 mmol l NaCl, 1 mmol l 2 depending on primer pair used) was used in all cases Na VO , 1X protease inhibitor cocktail (Boehringer   3  4 as an endogenous control for RNA quantity and Mannheim; Germany), 5% BSA). Proinsulin and quality. insulin levels were measured by ELISAs. Proinsulin and insulin were co-detected using a Rat Insulin kit which is 120%, 71% and ,0.05% cross-reactive with Immunocytochemical analysis human insulin, proinsulin and c-peptide, respectively (Mercodia AB, Uppsala, Sweden; 10-11-24-10). MaResults from expression of proinsulin, GLUT2 and ture insulin was assessed using a specific human glucokinase were determined by immunocytochemiinsulin ELISA (Mercodia AB; 10-11-13-10) which is cal analysis, as shown in Figure 2 . Transfection of PPI , 0.01% cross-reactive with proinsulin and c-peptide, resulted in the translation of the protein in the cytofollowing procedures provided by the manufacturers.
plasm of BHK-PPI-C16, while there was an absence Figure 1 . RT-PCR analysis of (A) Human PPI (B) glucokinase and (C) GLUT2 mRNA transcription in untransfected BHK21 cells, BHK-PPI-C16 cells, the glucokinase and glucokinase / GLUT2 co-expressing cell populations generated from BHK-PPI-C16. Approximately 5 ng of the appropriate cDNA and H O were used as the positive and negative controls, respectively. MW indicated molecular weight markers.
2 of staining in the parental BHK21 cell line. Immunothese antigens in the transfected populations as a cytochemical analysis for GLUT2 and glucokinase whole; there does appear however to be individual was not as clear due to the expression of these intensely stained cells within the transfected populaproteins in the untransfected cells. There is no noticetion but not in the control. The mouse b cell line, able increase in the intensity of the DAB staining for Min6, was used as a positive control in these analyses. Western Blot analysis PPI-C16-GCK-GLUT). Densitometric analysis, using b-actin as an endogenous control, did not indicate a Glucokinase significant increase in levels of this protein in either of As shown in Figure 3A , a single band for glucokinase the transfected populations. DLKP was used as a protein was detected at 50 kDa. This protein was positive control in these experiments. detected in non-transfected BHK-PPI-C16 cells and in both of the cell populations transfected with the GLUT2 glucokinase cDNA (BHK-PPI-C16-GCK and BHKSingle bands (approximately 60 kDa) corresponding Figure 3 . Western blot analysis of (A) glucokinase and (B) GLUT2 protein expression in the untransfected BHK-PPI-C16 cells and in the transfected populations. 50 mg of cellular lysate was subjected to polyacrylamide gel electrophoresis (PAGE), transferred onto nitrocellulose and probed with (A) goat anti glucokinase (Santa Cruz, Biotech) and (B) rabbit anti GLUT2 (Chemicon). Glucokinase expression was present in all BHK cell lines tested and densitometry using b-actin as a control did not indicate a significant difference in protein levels. GLUT2 expression was present in all cell lines tested and again was not significantly increased in the transfected populations. DLKP was used as a control lysate in both cases. The gels presented are representative blots of at least three independent experiments.
to GLUT2 protein were detected in BHK-PPI-C16, trol cell line, DLKP ( Figure 3B ). Densitometric anal-BHK-PPI-C16-GCK, the transfected population ysis of a number of blots did not indicate a significant BHK-PPI-C16-GCK-GLUT and in the positive conincrease in GLUT2 protein levels in the transfected population when normalised for levels of the endogcreased in the presence of agents designed to increase enous control b-actin.
cAMP. 3-isobutyl-methylxanthine (IBMX) and glucagon resulted in maximal stimulation (approxi-ELISA analysis mately 2 fold) over a 2-hour period of exposure ( Figure 6 ). Constitutive secretion and storage of proinsulin Proinsulin ELISA was used to determine the levels of proinsulin / insulin secreted and stored by BHK-PPIDiscussion C16. Over a 24 h period the BHK-PPI-C16 cells were found to secrete proinsulin at a rate of 0.12 pmol /
The data presented in this study demonstrate that the 5 hour / 10 cells while the cellular proinsulin content fibroblast cell line BHK21 can be engineered to
was relatively constant at 0.36 pmol l 6 0.04 produce and secrete human proinsulin in a single (Figure 4) . Thus the cells were secreting approximatemanipulation. As reported in other studies with fily 34% of their proinsulin each hour. The constitutive broblasts (Taniguchi et al. 1997) , the release of proinrelease of proinsulin from BHK-PPI-C16 has been sulin from BHK-PPI-C16 was constitutive and was stable for more than 12 mo. Use of a specific ELISA not accompanied by any traces of mature processed for processed human insulin indicated that there was insulin. These cells do not have the endopeptidase no secretion or storage of any mature human insulin.
enzymes, PC2 and PC3, and thus were unable to process the proinsulin formed to mature insulin.
Glucose stimulated insulin secretion
For non-b cell replacement therapy to be successful BHK-PPI-C16 was found to be insensitive to the there must be minute to minute regulation of the levels of glucose in the surrounding environment over patients blood glucose levels over the entire physiothe entire physiological range ( Figure 5A ). The cell logical range. It was found however that the BHKpopulation expressing GCK (BHK-PPI-C16-GCK)
PPI-C16 cells were insensitive to glucose levels in the demonstrated an almost two fold increase in proinsurrounding environment. These cells were found to sulin secretion at 2-5 mM glucose when compared to contain low levels of the two critical components of basal medium. Proinsulin secretion was undetectable the glucose sensing system (GLUT2 and glucokinase) in the BHK-PPI-C16-GCK-GLUT population (Figure thus these cDNAs were transfected in to the BHK-5B).
PPI-C16 proinsulin expressing cells. There did not appear to be significant translation of the transfected cAMP mediated stimulated secretion cDNAs, yet there were effects on insulin secretion. Secretion of proinsulin from BHK-PPI-C16 was inExpression of the glucokinase gene alone led to a Figure 4 . Proinsulin secretion and storage over a 24 hour period as measured by proinsulin ELISA. There was no processed human insulin in either the medium or the cellular lysates as measured using an ELISA for processed human insulin. The data represent the means 6 SD of at least three independent experiments. 2-fold stimulation of proinsulin secretion at approxia result of metabolic effects leading to an increase in 21 mately 2 mmol l glucose. This is below the physioproinsulin synthesis and thus secretion. This effect logical range of glucose concentrations that a b cell has already been described as a characteristic of would respond to (minimal stimulation occurs at fibroblasts (Kelly 1985) . The stimulation of secretion 21 approximately 4-5 mmol l ). There is an apparent in the glucokinase expressing population BHK-PPI-21 decrease in proinsulin secretion at glucose levels in C16-GCK at 5 mmol l may be also due to regula-21 excess of 5 mmol l indicating perhaps that the cells tion of secretion at the level of availability. This type are sensitive to glucose at high levels. A similar of regulated secretion would be similar to that decrease in insulin secretion following maximal achieved in fibroblasts using the inducible promoter stimulation at subphysiological levels has been found system (Kawakami et al. 1992) . to occur in AtT20 cells (Davies et al. 1998 ). Co-
In conclusion, BHK21 cells were successfully expression of both glucokinase and GLUT2 in the PPI transfected with the human PPI cDNA, but due to the expressing cell line BHK-PPI-C16 led to a complete apparent lack of a regulated storage and secretion eradication of insulin secretion while insulin mRNA pathway and the endopeptidases PC2 and PC3, only transcript level was unaffected ( Figure 1A) .
constitutive secretion of unprocessed proinsulin was Recombinant bacteria show altered metabolic and observed. These results are similar to those obtained proliferative profiles compared to wild type strains in this laboratory using the Vero fibroblast cell line due to the increased metabolic load of expressing the (O'Driscoll et al. 2002) . Co-transfection of glucose recombinant protein (Lee and Eldin 1985) . Recombisensing genes was insufficient to endow the cells with nant BHK cells were shown to be similarly affected appreciable glucose sensing capabilities. Thus these when G418 was present in the growth medium. It was cells may be of more use as a means of providing a found that G418 caused an increase in the level of the constant release of proinsulin, provided that the cells r neomycin resistance gene (neo ) encoded on the could be encapsulated with some biocompatible mar expression plasmid. The increased levels of neo were terial to prevent immunological rejection, implant found to increase the metabolic load of the BHK cells overgrowth and to control the rate of proinsulin (Yallop and Svedsen 2001) . No effects on growth and secretion. The cells would also have to be cultured metabolism were noted following the expression of under approved serum free conditions such as those r the neo containing pT-PPI plasmid in BHK-PPI-C16 described for BHK-21 cells by Merten et al. (1999) . cells. It is possible however that the subsequent transfection of the pcDNA3.1 / Zeocin (GLUT2) and the pcDNA3.1 / Hygromycin (Glucokinase) increased
